Gibson, Dunn & Crutcher LLP is advising Spyre Therapeutics, Inc. in the transaction, while Cooley LLPis advising Aeglea. Aeglea BioTherapeutics, Inc. (“Aeglea”) (NASDAQ: AGLE), announced it has completed...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here